We focus in particular on one of the most widely used GEMMs of pancreatic cancer, the LSL-KrasG12D; LSL-Trp53R172H;Pdx1-cre (KPC) model, and its use in the preclinical testing of anti-cancer agents. The gene discussed is PDX1; the disease is pancreatic neoplasm.